Phathom Pharmaceuticals Reports Third-Quarter Revenue of $84.7 Million

Phathom Pharmaceuticals reported third-quarter 2026 revenue of $84.7M, up 71.1% from $49.5M a year earlier. Net loss narrowed to $13.9M from $30M, while diluted EPS improved to $(0.16) from $(0.41).Financial HighlightsBusiness HighlightsOriginal SEC Filing: Phathom Pharmaceuticals, Inc. [ PHAT…

Phathom Pharmaceuticals reported third-quarter 2026 net revenue of $84.7 million, up 71% year over year, and a GAAP net loss of $13.9 million. The company recorded $3.0 million in non-GAAP adjusted net income and positive operating cash flow for a second consecutive quarter. Phathom reaffirmed its…